LABCORP HOLDINGS INC. Future Amortization Expense, Year One (Deprecated 2012-01-31)
LABCORP HOLDINGS INC. (LH) reported Future Amortization Expense, Year One (Deprecated 2012-01-31) of $84.80 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearOne · last filed 2013-02-26
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for the quarter ending 2012-12-31 was $61.70M.
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for the quarter ending 2012-09-30 was -$19.10M.
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$20.60M.
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $62.80M.
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for fiscal 2012 was $84.80M, a 1.07% increase from fiscal 2011.
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for fiscal 2011 was $83.90M, a 1.41% decline from fiscal 2010.
- LABCORP HOLDINGS INC. future amortization expense, year one (deprecated 2012-01-31) for fiscal 2010 was $85.10M.
| Period end | Future Amortization Expense, Year One (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Year One (Deprecated 2012-01-31) 6 month | Future Amortization Expense, Year One (Deprecated 2012-01-31) 9 month | Future Amortization Expense, Year One (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $61.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $42.60M derived: sum of 2 quarters · filed 2013-02-26 | $22.00M derived: sum of 3 quarters · filed 2013-02-26 | $84.80M 10-K · filed 2013-02-26 |
| 2012-09-30 | -$19.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-30 | -$39.70M derived: sum of 2 quarters · filed 2012-10-30 | $23.10M 10-Q · filed 2012-10-30 | |
| 2012-06-30 | -$20.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $42.20M 10-Q · filed 2012-08-02 | ||
| 2012-03-31 | $62.80M 10-Q · filed 2012-04-27 | |||
| 2011-12-31 | $83.90M 10-K · filed 2012-02-24 | |||
| 2010-12-31 | $85.10M 10-K/A · filed 2011-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |